<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37051747</PMID><DateCompleted><Year>2023</Year><Month>09</Month><Day>19</Day></DateCompleted><DateRevised><Year>2023</Year><Month>12</Month><Day>21</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1945-7197</ISSN><JournalIssue CitedMedium="Internet"><Volume>108</Volume><Issue>10</Issue><PubDate><Year>2023</Year><Month>Sep</Month><Day>18</Day></PubDate></JournalIssue><Title>The Journal of clinical endocrinology and metabolism</Title><ISOAbbreviation>J Clin Endocrinol Metab</ISOAbbreviation></Journal><ArticleTitle>Low Vitamin D Levels Are Associated With Long COVID Syndrome in COVID-19 Survivors.</ArticleTitle><Pagination><StartPage>e1106</StartPage><EndPage>e1116</EndPage><MedlinePgn>e1106-e1116</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1210/clinem/dgad207</ELocationID><Abstract><AbstractText Label="CONTEXT">Long COVID is an emerging syndrome affecting 50% to 70% of COVID-19 survivors that still lacks predicting factors.</AbstractText><AbstractText Label="OBJECTIVE">Due to the extraskeletal effects of vitamin D, we retrospectively assessed the association between 25(OH) vitamin D levels and long COVID in COVID-19 survivors 6 months after hospitalization.</AbstractText><AbstractText Label="METHODS">Long COVID was defined according to NICE guidelines. Fifty long COVID and 50 non-long-COVID subjects matched on a 1:1 basis were enrolled from an outpatient clinic post-COVID cohort seen from August to November 2020. Therapies/comorbidities affecting calcium/vitamin D/bone metabolism, and/or admission to the intensive care unit during hospitalization were exclusion criteria. 25(OH) Vitamin D was measured at hospital admission and 6 months after discharge.</AbstractText><AbstractText Label="RESULTS">We observed lower 25(OH) vitamin D levels, evaluated at follow-up, in subjects with long COVID than those without (20.1 vs 23.2 ng/mL, P = .03). Regarding the affected health areas evaluated in the entire cohort, we observed lower 25(OH) vitamin D levels in those with neurocognitive symptoms at follow-up (n = 7) than those without (n = 93) (14.6 vs 20.6 ng/mL, P = .042). In patients presenting vitamin D deficiency (&lt;20 ng/mL), both at admission and at follow-up (n = 42), those affected by long COVID (n = 22) presented lower 25(OH) vitamin D levels at follow-up than those not affected (n = 20) (12.7 vs 15.2 ng/mL, P = .041). In multiple regression analyses, lower 25(OH) vitamin D levels at follow-up were the only variable significantly associated with long COVID in our cohort (P = .008, OR 1.09, CI 1.01-1.16).</AbstractText><AbstractText Label="CONCLUSION">COVID-19 survivors with long COVID have lower 25(OH) vitamin D levels than matched patients without long COVID. Our data suggest that vitamin D levels should be evaluated in COVID-19 patients after hospital discharge. The role of vitamin D supplementation as a preventive strategy of COVID-19 sequelae should be tested in randomized controlled trials.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2023. Published by Oxford University Press on behalf of the Endocrine Society.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>di Filippo</LastName><ForeName>Luigi</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Institute of Endocrine and Metabolic Sciences, Universit&#xe0; Vita-Salute San Raffaele, IRCCS Ospedale San Raffaele, Milan 20132, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Frara</LastName><ForeName>Stefano</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Institute of Endocrine and Metabolic Sciences, Universit&#xe0; Vita-Salute San Raffaele, IRCCS Ospedale San Raffaele, Milan 20132, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nannipieri</LastName><ForeName>Fabrizio</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Clinical Research, Abiogen Pharma, Pisa 56121, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cotellessa</LastName><ForeName>Alice</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Laboratory Medicine Service, IRCCS Ospedale San Raffaele, Milan 20132, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Locatelli</LastName><ForeName>Massimo</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Laboratory Medicine Service, IRCCS Ospedale San Raffaele, Milan 20132, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rovere Querini</LastName><ForeName>Patrizia</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0003-2615-3649</Identifier><AffiliationInfo><Affiliation>Division of Immunology, Transplantation &amp; Infectious Diseases, Universit&#xe0; Vita-Salute San Raffaele, IRCCS Ospedale San Raffaele, Milan 20132, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giustina</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-6783-3398</Identifier><AffiliationInfo><Affiliation>Institute of Endocrine and Metabolic Sciences, Universit&#xe0; Vita-Salute San Raffaele, IRCCS Ospedale San Raffaele, Milan 20132, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Clin Endocrinol Metab</MedlineTA><NlmUniqueID>0375362</NlmUniqueID><ISSNLinking>0021-972X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>1406-16-2</RegistryNumber><NameOfSubstance UI="D014807">Vitamin D</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014815">Vitamins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>J Clin Endocrinol Metab. 2023 Dec 21;109(1):e430-e431. doi: 10.1210/clinem/dgad338</RefSource><PMID Version="1">37279939</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014807" MajorTopicYN="N">Vitamin D</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014808" MajorTopicYN="Y">Vitamin D Deficiency</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014815" MajorTopicYN="N">Vitamins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017741" MajorTopicYN="N">Survivors</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">hypovitaminosis D</Keyword><Keyword MajorTopicYN="N">vitamin D</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>2</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>9</Month><Day>19</Day><Hour>6</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>14</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>13</Day><Hour>3</Hour><Minute>53</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>4</Month><Day>13</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37051747</ArticleId><ArticleId IdType="pmc">PMC10505553</ArticleId><ArticleId IdType="doi">10.1210/clinem/dgad207</ArticleId><ArticleId IdType="pii">7116659</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Bilezikian JP, Binkley N, De Luca HF, et al. . Consensus and controversial aspects of vitamin D and COVID-19. J Clin Endocrinol Metab. 2023;108(5):1034&#x2013;1042.</Citation><ArticleIdList><ArticleId IdType="pubmed">36477486</ArticleId></ArticleIdList></Reference><Reference><Citation>Dissanayake HA, de Silva NL, Sumanatilleke M, et al. . Prognostic and therapeutic role of vitamin D in COVID-19: systematic review and meta-analysis. J Clin Endocrinol Metab. 2022;107(5):1484&#x2010;1502.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8689831</ArticleId><ArticleId IdType="pubmed">34894254</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiodini I, Gatti D, Soranna D, et al. . Vitamin D status and SARS-CoV-2 infection and COVID-19 clinical outcomes. Front Public Health. 2021;9:736665.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8727532</ArticleId><ArticleId IdType="pubmed">35004568</ArticleId></ArticleIdList></Reference><Reference><Citation>Akbar MR, Wibowo A, Pranata R, Setiabudiawan B. Low serum 25-hydroxyvitamin D (vitamin D) level is associated with susceptibility to COVID-19, severity, and mortality: a systematic review and meta-analysis. Front Nutr. 2021;8:660420.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8039288</ArticleId><ArticleId IdType="pubmed">33855042</ArticleId></ArticleIdList></Reference><Reference><Citation>di Filippo L, Allora A, Doga M, et al. . Vitamin D levels are associated with blood glucose and BMI in COVID-19 patients, predicting disease severity. J Clin Endocrinol Metab. 2022;107(1):e348&#x2010;e360.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8385994</ArticleId><ArticleId IdType="pubmed">34383926</ArticleId></ArticleIdList></Reference><Reference><Citation>Bogliolo L, Cereda E, Klersy C, et al. . Vitamin D 25OH deficiency and mortality in moderate to severe COVID-19: a multi-center prospective observational study. Front Nutr. 2022;9:934258.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9296047</ArticleId><ArticleId IdType="pubmed">35866079</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalichuran S, van Blydenstein SA, Venter M, Omar S. Vitamin D status and COVID-19 severity. S Afr J Infect Dis. 2022;37(1):359.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9082083</ArticleId><ArticleId IdType="pubmed">35546959</ArticleId></ArticleIdList></Reference><Reference><Citation>Parra-Ortega I, Alcara-Ram&#xed;rez DG, Ronzon-Ronzon AA, et al. . 25-Hydroxyvitamin D level is associated with mortality in patients with critical COVID-19: a prospective observational study in Mexico City. Nutr Res Pract. 2021;15(Suppl 1):S32&#x2010;S40.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8636388</ArticleId><ArticleId IdType="pubmed">34909131</ArticleId></ArticleIdList></Reference><Reference><Citation>Campi I, Gennari L, Merlotti D, et al. . Vitamin D and COVID-19 severity and related mortality: a prospective study in Italy. BMC Infect Dis. 2021;21(1):566.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8200788</ArticleId><ArticleId IdType="pubmed">34126960</ArticleId></ArticleIdList></Reference><Reference><Citation>Bianconi V, Mannarino MR, Figorilli F, et al. . Prevalence of vitamin D deficiency and its prognostic impact on patients hospitalized with COVID-19. Nutrition. 2021;91-92:111408.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8247197</ArticleId><ArticleId IdType="pubmed">34388589</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-de-Las-Pe&#xf1;as C, Palacios-Ce&#xf1;a D, G&#xf3;mez-Mayordomo V, Cuadrado ML, Florencio LL. Defining post-COVID symptoms (post-acute COVID, long COVID, persistent post-COVID): an integrative classification. Int J Environ Res Public Health. 2021;18(5):2621.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7967389</ArticleId><ArticleId IdType="pubmed">33807869</ArticleId></ArticleIdList></Reference><Reference><Citation>
National Institute for Health and Care Excellence (NICE), Royal College of General Practitioners, Healthcare Improvement Scotland SIGN . COVID-19 Rapid Guideline: Managing the Long-Term Effects of COVID-19. National Institute for Health and Care Excellence; 2020. Accessed 30 December, 2020. www.nice.org.uk/guidance/ng188</Citation></Reference><Reference><Citation>Sivan M, Taylor S. NICE Guideline on long COVID. BMJ. 2020;371:m4938.</Citation><ArticleIdList><ArticleId IdType="pubmed">33361141</ArticleId></ArticleIdList></Reference><Reference><Citation>Notarte KI, de Oliveira MHS, Peligro PJ, et al. . Age, sex and previous comorbidities as risk factors not associated with SARS-CoV-2 infection for long COVID-19: a systematic review and meta-analysis. J Clin Med. 2022;11(24):7314.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9787827</ArticleId><ArticleId IdType="pubmed">36555931</ArticleId></ArticleIdList></Reference><Reference><Citation>Maglietta G, Diodati F, Puntoni M, et al. . Prognostic factors for post-COVID-19 syndrome: a systematic review and meta-analysis. J Clin Med. 2022;11(6):1541.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8948827</ArticleId><ArticleId IdType="pubmed">35329867</ArticleId></ArticleIdList></Reference><Reference><Citation>Bouillon R, Marcocci C, Carmeliet G, et al. . Skeletal and extraskeletal actions of vitamin D: current evidence and outstanding questions. Endocr Rev. 2019;40(4):1109&#x2010;1151.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6626501</ArticleId><ArticleId IdType="pubmed">30321335</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilezikian JP, Bikle D, Hewison M, et al. . Mechanisms in endocrinology: vitamin D and COVID-19. Eur J Endocrinol. 2020;183(5):R133&#x2010;R147.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9494342</ArticleId><ArticleId IdType="pubmed">32755992</ArticleId></ArticleIdList></Reference><Reference><Citation>Charoenngam N, Holick MF. Immunologic effects of vitamin D on human health and disease. Nutrients. 2020;12(7):2097.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7400911</ArticleId><ArticleId IdType="pubmed">32679784</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia M, Seelaender M, Sotiropoulos A, Coletti D, Lancha AH Jr. Vitamin D, muscle recovery, sarcopenia, cachexia, and muscle atrophy. Nutrition. 2019;60:66&#x2010;69.</Citation><ArticleIdList><ArticleId IdType="pubmed">30529188</ArticleId></ArticleIdList></Reference><Reference><Citation>Olsson K, Saini A, Str&#xf6;mberg A, et al. . Evidence for vitamin D receptor expression and direct effects of 1&#x3b1;, 25(OH)2D3 in human skeletal muscle precursor cells. Endocrinology. 2016;157(1):98&#x2010;111.</Citation><ArticleIdList><ArticleId IdType="pubmed">26469137</ArticleId></ArticleIdList></Reference><Reference><Citation>Wagatsuma A, Sakuma K. Vitamin D signaling in myogenesis: potential for treatment of sarcopenia. Biomed Res Int. 2014;2014:121254.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4147791</ArticleId><ArticleId IdType="pubmed">25197630</ArticleId></ArticleIdList></Reference><Reference><Citation>Plotnikoff GA, Quigley JM. Prevalence of severe hypovitaminosis D in patients with persistent, nonspecific musculoskeletal pain. Mayo Clin Proc. 2003;78(12):1463&#x2010;1470.</Citation><ArticleIdList><ArticleId IdType="pubmed">14661675</ArticleId></ArticleIdList></Reference><Reference><Citation>Makrani AH, Afshari M, Ghajar M, Forooghi Z, Moosazadeh M. Vitamin D and fibromyalgia: a meta-analysis. Korean J Pain. 2017;30(4):250&#x2010;257.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5665736</ArticleId><ArticleId IdType="pubmed">29123619</ArticleId></ArticleIdList></Reference><Reference><Citation>Ellis SD, Kelly ST, Shurlock JH, Hepburn ALN. The role of vitamin D testing and replacement in fibromyalgia: a systematic literature review. BMC Rheumatol. 2018;2:28.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6390590</ArticleId><ArticleId IdType="pubmed">30886978</ArticleId></ArticleIdList></Reference><Reference><Citation>Khairy EY, Attia MM. Protective effects of vitamin D on neurophysiologic alterations in brain aging: role of brain-derived neurotrophic factor (BDNF). Nutr Neurosci. 2021;24(8):650&#x2010;659.</Citation><ArticleIdList><ArticleId IdType="pubmed">31524100</ArticleId></ArticleIdList></Reference><Reference><Citation>Nowaczewska M, Wici&#x144;ski M, Osi&#x144;ski S, Ka&#x17a;mierczak H. The role of vitamin D in primary headache-from potential mechanism to treatment. Nutrients. 2020;12(1):243.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7019347</ArticleId><ArticleId IdType="pubmed">31963460</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xe1;ll Z, Sz&#xe9;kely O. Role of vitamin D in cognitive dysfunction: new molecular concepts and discrepancies between animal and human findings. Nutrients. 2021;13(11):3672.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8620681</ArticleId><ArticleId IdType="pubmed">34835929</ArticleId></ArticleIdList></Reference><Reference><Citation>Jolliffe DA, Camargo CA Jr, Sluyter JD, et al. . Vitamin D supplementation to prevent acute respiratory infections: a systematic review and meta-analysis of aggregate data from randomised controlled trials. Lancet Diabetes Endocrinol. 2021;9(5):276&#x2010;292.</Citation><ArticleIdList><ArticleId IdType="pubmed">33798465</ArticleId></ArticleIdList></Reference><Reference><Citation>Haugen J, Basnet S, Hardang IM, et al. . Vitamin D status is associated with treatment failure and duration of illness in Nepalese children with severe pneumonia. Pediatr Res. 2017;82(6):986&#x2010;993.</Citation><ArticleIdList><ArticleId IdType="pubmed">28678771</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L, Dyer AH, McCluskey P, et al. . Investigating the relationship between vitamin D and persistent symptoms following SARS-CoV-2 infection. Nutrients. 2021;13(7):2430.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8308626</ArticleId><ArticleId IdType="pubmed">34371940</ArticleId></ArticleIdList></Reference><Reference><Citation>Caballero-Garc&#xed;a A, P&#xe9;rez-Valdecantos D, Guallar P, et al. . Effect of vitamin D supplementation on muscle status in old patients recovering from COVID-19 infection. Medicina (Kaunas). 2021;57(10):1079.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8537350</ArticleId><ArticleId IdType="pubmed">34684116</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohamed Hussein AAR, Galal I, Amin MT, et al. . Prevalence of vitamin D deficiency among patients attending post COVID-19 follow-up clinic: a cross-sectional study. Eur Rev Med Pharmacol Sci. 2022;26(8):3038&#x2010;3045.</Citation><ArticleIdList><ArticleId IdType="pubmed">35503606</ArticleId></ArticleIdList></Reference><Reference><Citation>Galluzzo V, Ciciarello F, Tosato M, et al. . Association between vitamin D status and physical performance in COVID-19 survivors: results from the Gemelli against COVID-19 post-acute care project. Mech Ageing Dev. 2022;205:111684.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9093083</ArticleId><ArticleId IdType="pubmed">35568146</ArticleId></ArticleIdList></Reference><Reference><Citation>Fernandes AL, Sales LP, Santos MD, Caparbo VF, Murai IH, Pereira RMR. Persistent or new symptoms 1 year after a single high dose of vitamin D3 in patients with moderate to severe COVID-19. Front Nutr. 2022;9:979667.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9513442</ArticleId><ArticleId IdType="pubmed">36176639</ArticleId></ArticleIdList></Reference><Reference><Citation>Rovere-Querini P, Tresoldi C, Conte C, et al. . Biobanking for COVID-19 research. Panminerva Med. 2020;64(2):244&#x2010;252.</Citation><ArticleIdList><ArticleId IdType="pubmed">33073557</ArticleId></ArticleIdList></Reference><Reference><Citation>Rovere Querini P, De Lorenzo R, Conte C, et al. . Post-COVID-19 follow-up clinic: depicting chronicity of a new disease. Acta Biomed. 2020;91(9-S):22&#x2010;28.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8023087</ArticleId><ArticleId IdType="pubmed">32701913</ArticleId></ArticleIdList></Reference><Reference><Citation>Sempos CT, Heijboer AC, Bikle DD, et al. . Vitamin D assays and the definition of hypovitaminosis D: results from the first international conference on controversies in vitamin D. Br J Clin Pharmacol. 2018;84(10):2194&#x2010;2207.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6138489</ArticleId><ArticleId IdType="pubmed">29851137</ArticleId></ArticleIdList></Reference><Reference><Citation>De Lorenzo R, Conte C, Lanzani C, et al. . Residual clinical damage after COVID-19: A retrospective and prospective observational cohort study. PLoS One. 2020;15(10):e0239570.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7556454</ArticleId><ArticleId IdType="pubmed">33052920</ArticleId></ArticleIdList></Reference><Reference><Citation>di Filippo L, Uygur M, Locatelli M, Nannipieri F, Frara S, Giustina A. Low vitamin D levels predict outcomes of COVID-19 in patients with both severe and non-severe disease at hospitalization. Endocrine. Published online March 1, 2023. Doi: 10.1007/s12020-023-03331-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12020-023-03331-9</ArticleId><ArticleId IdType="pmc">PMC9974397</ArticleId><ArticleId IdType="pubmed">36854858</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Filippo L, Formenti AM, Rovere-Querini P, et al. . Hypocalcemia is highly prevalent and predicts hospitalization in patients with COVID-19. Endocrine. 2020;68(3):475&#x2010;478.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7292572</ArticleId><ArticleId IdType="pubmed">32533508</ArticleId></ArticleIdList></Reference><Reference><Citation>di Filippo L, Doga M, Frara S, Giustina A. Hypocalcemia in COVID-19: prevalence, clinical significance and therapeutic implications. Rev Endocr Metab Disord. 2022:23(2):299&#x2010;308.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8041474</ArticleId><ArticleId IdType="pubmed">33846867</ArticleId></ArticleIdList></Reference><Reference><Citation>di Filippo L, Formenti AM, Doga M, Pedone E, Rovere-Querini P, Giustina A. Radiological thoracic vertebral fractures are highly prevalent in COVID-19 and predict disease outcomes. J Clin Endocrinol Metab. 2021;106(2):e602&#x2010;e614.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7797741</ArticleId><ArticleId IdType="pubmed">33159451</ArticleId></ArticleIdList></Reference><Reference><Citation>di Filippo L, Compagnone N, Frara S, et al. . Vertebral fractures at hospitalization predict impaired respiratory function during follow-up of COVID-19 survivors. Endocrine. 2022;77(2):392&#x2010;400.</Citation><ArticleIdList><ArticleId IdType="pubmed">35676466</ArticleId></ArticleIdList></Reference><Reference><Citation>di Filippo L, Frara S, Giustina A. The emerging osteo-metabolic phenotype of COVID-19: clinical and pathophysiological aspects. Nat Rev Endocrinol. 2021;17(8):445&#x2010;446.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8170860</ArticleId><ArticleId IdType="pubmed">34079100</ArticleId></ArticleIdList></Reference><Reference><Citation>di Filippo L, Frara S, Doga M, Giustina A. The osteo-metabolic phenotype of COVID-19: an update. Endocrine. 2022;78(2):247&#x2010;254.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9297261</ArticleId><ArticleId IdType="pubmed">35857271</ArticleId></ArticleIdList></Reference><Reference><Citation>Giustina A, Bilezikian JP. Revisiting the endocrine and metabolic manifestations of COVID-19 two years into the pandemic. Rev Endocr Metab Disord. 2022;23(2):133&#x2010;136.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8857394</ArticleId><ArticleId IdType="pubmed">35182326</ArticleId></ArticleIdList></Reference><Reference><Citation>Gameil MA, Marzouk RE, Elsebaie AH, Rozaik SE. Long-term clinical and biochemical residue after COVID-19 recovery. Egypt Liver J. 2021;11(1):74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8435147</ArticleId><ArticleId IdType="pubmed">34777873</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilezikian JP, Formenti AM, Adler RA, et al. . Vitamin D: dosing, levels, form, and route of administration: does one approach fit all? Rev Endocr Metab Disord. 2021;22(4):1201&#x2010;1218.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8696970</ArticleId><ArticleId IdType="pubmed">34940947</ArticleId></ArticleIdList></Reference><Reference><Citation>Conti V, Corbi G, Sabbatino F, et al. . Long COVID: clinical framing, biomarkers, and therapeutic approaches. J Pers Med. 2023;13(2):334.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9959656</ArticleId><ArticleId IdType="pubmed">36836568</ArticleId></ArticleIdList></Reference><Reference><Citation>Gal&#xe1;n M, Vig&#xf3;n L, Fuertes D, et al. . Persistent overactive cytotoxic immune response in a Spanish cohort of individuals with Long-COVID: identification of diagnostic biomarkers. Front Immunol. 2022;13:848886.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8990790</ArticleId><ArticleId IdType="pubmed">35401523</ArticleId></ArticleIdList></Reference><Reference><Citation>Kedor C, Freitag H, Meyer-Arndt L, et al. . A prospective observational study of post-COVID-19 chronic fatigue syndrome following the first pandemic wave in Germany and biomarkers associated with symptom severity. Nat Commun. 2022;13(1):5104.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9426365</ArticleId><ArticleId IdType="pubmed">36042189</ArticleId></ArticleIdList></Reference><Reference><Citation>Garc&#xed;a-Abell&#xe1;n J, Fern&#xe1;ndez M, Padilla S, et al. . Immunologic phenotype of patients with long-COVID syndrome of 1-year duration. Front Immunol. 2022;13:920627.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9451924</ArticleId><ArticleId IdType="pubmed">36090973</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandal S, Barnett J, Brill SE, et al. . &#x2018;Long-COVID&#x2019;: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax. 2021;76(4):396&#x2010;398.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7615158</ArticleId><ArticleId IdType="pubmed">33172844</ArticleId></ArticleIdList></Reference><Reference><Citation>Clemente I, Sinatti G, Cirella A, Santini SJ, Balsano C. Alteration of inflammatory parameters and psychological post-traumatic syndrome in long-COVID patients. Int J Environ Res Public Health. 2022;19(12):7103.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9222533</ArticleId><ArticleId IdType="pubmed">35742355</ArticleId></ArticleIdList></Reference><Reference><Citation>Giustina A, Adler RA, Binkley N, et al. . Consensus statement from 2nd international conference on controversies in vitamin D. Rev Endocr Metab Disord. 2020;21(1):89&#x2010;116.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7113202</ArticleId><ArticleId IdType="pubmed">32180081</ArticleId></ArticleIdList></Reference><Reference><Citation>Puig-Domingo M, Marazuela M, Yildiz BO, Giustina A. COVID-19 and endocrine and metabolic diseases. An updated statement from the European Society of Endocrinology. Endocrine. 2021;72(2):301&#x2010;316.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8105151</ArticleId><ArticleId IdType="pubmed">33963516</ArticleId></ArticleIdList></Reference><Reference><Citation>Giustina A. Hypovitaminosis D and the endocrine phenotype of COVID-19. Endocrine. 2021;72(1):1&#x2010;11.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7972333</ArticleId><ArticleId IdType="pubmed">33738708</ArticleId></ArticleIdList></Reference><Reference><Citation>Giustina A, Bouillon R, Binkley N, et al. . Controversies in vitamin D: a statement from the third international conference. JBMR Plus. 2020;4(12):e10417.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7745884</ArticleId><ArticleId IdType="pubmed">33354643</ArticleId></ArticleIdList></Reference><Reference><Citation>Tecilazich F, Formenti AM, Giustina A. Role of vitamin D in diabetic retinopathy: pathophysiological and clinical aspects. Rev Endocr Metab Disord. 2021;22(4):715&#x2010;727.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7538371</ArticleId><ArticleId IdType="pubmed">33026598</ArticleId></ArticleIdList></Reference><Reference><Citation>Maddaloni E, Cavallari I, Napoli N, Conte C. Vitamin D and diabetes mellitus. Front Horm Res. 2018;50:161&#x2010;176.</Citation><ArticleIdList><ArticleId IdType="pubmed">29597238</ArticleId></ArticleIdList></Reference><Reference><Citation>Raveendran AV, Misra A. Post COVID-19 syndrome (&#x201c;long COVID&#x201d;) and diabetes: challenges in diagnosis and management. Diabetes Metab Syndr. 2021;15(5):102235.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8317446</ArticleId><ArticleId IdType="pubmed">34384972</ArticleId></ArticleIdList></Reference><Reference><Citation>Su Y, Yuan D, Chen DG, et al. . Multiple early factors anticipate post-acute COVID-19 sequelae. Cell. 2022;185(5):881&#x2010;895.e20.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8786632</ArticleId><ArticleId IdType="pubmed">35216672</ArticleId></ArticleIdList></Reference><Reference><Citation>Alkodaymi MS, Omrani OA, Fawzy NA, et al. . Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis. Clin Microbiol Infect. 2022;28(5):657&#x2010;666.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8812092</ArticleId><ArticleId IdType="pubmed">35124265</ArticleId></ArticleIdList></Reference><Reference><Citation>Al Dossari KK, Ahmad G, Aljowair A, et al. . Association of vitamin D with glycemic control in Saudi patients with type 2 diabetes: a retrospective chart review study in an emerging university hospital. J Clin Lab Anal. 2020;34(2):e23048.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7031596</ArticleId><ArticleId IdType="pubmed">31568604</ArticleId></ArticleIdList></Reference><Reference><Citation>Afzal S, Bojesen SE, Nordestgaard BG. Low 25-hydroxyvitamin D and risk of type 2 diabetes: a prospective cohort study and metaanalysis. Clin Chem. 2013;59(2):381&#x2010;391.</Citation><ArticleIdList><ArticleId IdType="pubmed">23232064</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsur A, Feldman BS, Feldhammer I, Hoshen MB, Leibowitz G, Balicer RD. Decreased serum concentrations of 25-hydroxycholecalciferol are associated with increased risk of progression to impaired fasting glucose and diabetes. Diabetes Care. 2013;36(5):1361&#x2010;1367.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3631845</ArticleId><ArticleId IdType="pubmed">23393216</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Al-Aly Z. Risks and burdens of incident diabetes in long COVID: a cohort study. Lancet Diabetes Endocrinol. 2022;10(5):311&#x2010;321.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8937253</ArticleId><ArticleId IdType="pubmed">35325624</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang T, Mei Q, Zhang Z, et al. . Risk for newly diagnosed diabetes after COVID-19: a systematic review and meta-analysis. BMC Med. 2022;20(1):444.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9666960</ArticleId><ArticleId IdType="pubmed">36380329</ArticleId></ArticleIdList></Reference><Reference><Citation>Lai H, Yang M, Sun M, et al. . Risk of incident diabetes after COVID-19 infection: a systematic review and meta-analysis. Metabolism. 2022;137:155330.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9546784</ArticleId><ArticleId IdType="pubmed">36220361</ArticleId></ArticleIdList></Reference><Reference><Citation>Banerjee M, Pal R, Dutta S. Risk of incident diabetes post-COVID-19: a systematic review and meta-analysis. Prim Care Diabetes. 2022;16(4):591&#x2010;593.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9148988</ArticleId><ArticleId IdType="pubmed">35654679</ArticleId></ArticleIdList></Reference><Reference><Citation>Shrestha DB, Budhathoki P, Raut S, et al. . New-onset diabetes in COVID-19 and clinical outcomes: a systematic review and meta-analysis. World J Virol. 2021;10(5):275&#x2010;287.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8474977</ArticleId><ArticleId IdType="pubmed">34631477</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>